期刊文献+

连续性肾脏替代治疗在尿毒症合并心力衰竭中的应用 被引量:6

Application of continuous renal replacement therapy in patients with uremia accompanied by heart failure
暂未订购
导出
摘要 目的 评价和比较连续性肾脏替代治疗(CRRT)和间歇性血液透析(IHD)在控制尿毒症合并心力衰竭时的疗效。方法 48例合并心力衰竭的尿毒症患者分两组,一组采用CRRT,20例;另一组采用IHD,28例。分别观察两组治疗前后心功能改善情况。结果 CRRT组心功能明显改善,且明显好于IHD组。结论 连续性肾脏替代治疗较间歇性血液透析能更好地控制尿毒症合并心力衰竭。 Objective To evaluate and compare the clinical effect of continuous renal replacement therapy (CRRT) and intermittent hemodialysis (IHD) on beating uremia patients accompanied by heart failure. Methods Fourty - eight patients suffered from uremia accompanied by heart failure were divided into two groups. Twenty cases in CRRT group received CRRT therapy. Tuenty - eight cases in IHD group received IHD therapy. Improvement of heart function of two groups after treatment was observed and evaluated. Results The heart function after CRRT was improved obviously and was better than that after IHD. Conclusion The clinical effect of CRRT was more obvious than IHD in improving the heart function of uremia patients accompanied by heart failure.
作者 姚峥 贾强
出处 《中国血液净化》 2003年第11期601-603,共3页 Chinese Journal of Blood Purification
关键词 连续性肾脏替代治疗 尿毒症 合并症 心力衰竭 间歇性血液透析 Continuous renal replacement therapy Uremia Heart failure Hemodialysis
  • 相关文献

参考文献4

二级参考文献23

  • 1叶任高 谢桐.急性肾功能衰竭诊断标准[J].新医学,1983,14:2-2.
  • 2季大玺 谢红浪 等.连续性肾脏替代治疗在重症肾功能衰竭救治中的应用[J].肾脏病与透析肾移植杂志,1997,6:415-415.
  • 3季大玺 谢红浪 等.连续性肾脏替代治疗在烧伤后急性肾衰中应用[J].肾脏病与透析肾移植杂志,1998,6:581-581.
  • 4[1]Uren NG, Melin JA. De Bruyne B et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis N Engl J Med,1994,330:1782
  • 5[2]Amann K, Wiest G, Neusub R et al. Vascular hypertrophy in uremia is independent of hypertension. Am J Hypertens,1995,8:409
  • 6[3]Foley RN, Parfrey PS, Harnett JD et al. The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal disease. Am J Kidney Dis,1996,28:53
  • 7[4]Besarab A,Bolton WK, Browne JK et al.The effects of normal. as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and Epoietin. N Engl J Med,1998,339:584
  • 8[5]Harnett JD, Kent GM, Barre PE et al. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol,1994,4:1486
  • 9[6]Greaves SC, Gamble GD, Collins JF et al. Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis,1994,24:768
  • 10[7]Raine AEG. Acquired aortic stenosis in dialysis patients. Nephron,1994,68:159

共引文献210

同被引文献31

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部